BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10484017)

  • 1. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.
    Uehara H; Nakaizumi A; Baba M; Iishi H; Tatsuta M; Kitamura T; Ohigashi H; Ishikawa O; Takenaka A; Ishiguro S
    Am J Gastroenterol; 1996 Aug; 91(8):1616-21. PubMed ID: 8759672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to diagnosis of patients with pancreatic cancer: comparison with K-ras mutation.
    Yamaguchi Y; Watanabe H; Yrdiran S; Ohtsubo K; Motoo Y; Okai T; Sawabu N
    Clin Cancer Res; 1999 May; 5(5):1147-53. PubMed ID: 10353750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
    Lu X; Xu T; Qian J; Wen X; Wu D
    Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and K-ras mutations in pancreatic juice samples from patients with chronic pancreatitis.
    Löhr M; Müller P; Mora J; Brinkmann B; Ostwald C; Farré A; Lluis F; Adam U; Stubbe J; Plath F; Nizze H; Hopt UT; Barten M; Capellá G; Liebe S
    Gastrointest Endosc; 2001 Jun; 53(7):734-43. PubMed ID: 11375580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
    Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].
    Lu X; Xu T; Qian J
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1050-3. PubMed ID: 11758254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diagnosis of pancreatic cancer.
    Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(1):39-44. PubMed ID: 12021896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation.
    Myung SJ; Kim MH; Kim YS; Kim HJ; Park ET; Yoo KS; Lim BC; Wan Seo D; Lee SK; Min YI; Kim JY
    Gastrointest Endosc; 2000 Jun; 51(6):708-13. PubMed ID: 10840305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma.
    Tada M; Omata M; Kawai S; Saisho H; Ohto M; Saiki RK; Sninsky JJ
    Cancer Res; 1993 Jun; 53(11):2472-4. PubMed ID: 8495407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
    Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
    Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
    Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of pancreatic cancer by cytology and telomerase activity in exfoliated cells obtained by pancreatic duct brushing during endoscopy.
    Zhou GX; Huang JF; Zhang H; Chen JP
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):308-11. PubMed ID: 17548257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
    Dai MH; Zhao YP; Cai LX; Zhu Y
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of K-ras codon 12 point mutation in pancreatic juice in the diagnosis of carcinoma of the pancreas.
    Kimura W; Zhao B; Futakawa N; Muto T; Makuuchi M
    Hepatogastroenterology; 1999; 46(25):532-9. PubMed ID: 10228857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ki-ras mutation as a molecular tumor marker for carcinoma of the pancreas].
    Daus H; Trümper L; Bürger B; Jacobs G; Kriener S; von Blohn G; Zeitz M; Pfreundschuh M
    Dtsch Med Wochenschr; 1995 Jun; 120(23):821-5. PubMed ID: 7781522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.